GI Dynamics Announces up to ~US$10 Million Financing with Crystal Amber – Defers Potential ASX Delisting – Extends Maturity Date of 2017 Convertible Note – General Corporate Update

BOSTON and SYDNEY — 22 August 2019 — GI Dynamics® Inc. (ASX:GID) (Company or GI Dynamics), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that it has agreed to the terms of a financing...